Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial

Manfred Lamprecht, Simon Bogner, Gert Schippinger, Kurt Steinbauer, Florian Fankhauser, Seth Hallstroem, Burkhard Schuetz, Joachim F Greilberger, Manfred Lamprecht, Simon Bogner, Gert Schippinger, Kurt Steinbauer, Florian Fankhauser, Seth Hallstroem, Burkhard Schuetz, Joachim F Greilberger

Abstract

Background: Probiotics are an upcoming group of nutraceuticals claiming positive effects on athlete's gut health, redox biology and immunity but there is lack of evidence to support these statements.

Methods: We conducted a randomized, double-blinded, placebo controlled trial to observe effects of probiotic supplementation on markers of intestinal barrier, oxidation and inflammation, at rest and after intense exercise. 23 trained men received multi-species probiotics (1010 CFU/day, Ecologic®Performance or OMNi-BiOTiC®POWER, n = 11) or placebo (n = 12) for 14 weeks and performed an intense cycle ergometry over 90 minutes at baseline and after 14 weeks. Zonulin and α1-antitrypsin were measured from feces to estimate gut leakage at baseline and at the end of treatment. Venous blood was collected at baseline and after 14 weeks, before and immediately post exercise, to determine carbonyl proteins (CP), malondialdehyde (MDA), total oxidation status of lipids (TOS), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). Statistical analysis used multifactorial analysis of variance (ANOVA). Level of significance was set at p < 0.05, a trend at p < 0.1.

Results: Zonulin decreased with supplementation from values slightly above normal into normal ranges (<30 ng/ml) and was significantly lower after 14 weeks with probiotics compared to placebo (p = 0.019). We observed no influence on α1-antitrypsin (p > 0.1). CP increased significantly from pre to post exercise in both groups at baseline and in the placebo group after 14 weeks of treatment (p = 0.006). After 14 weeks, CP concentrations were tendentially lower with probiotics (p = 0.061). TOS was slightly increased above normal in both groups, at baseline and after 14 weeks of treatment. There was no effect of supplementation or exercise on TOS. At baseline, both groups showed considerably higher TNF-α concentrations than normal. After 14 weeks TNF-α was tendentially lower in the supplemented group (p = 0.054). IL-6 increased significantly from pre to post exercise in both groups (p = 0.001), but supplementation had no effect. MDA was not influenced, neither by supplementation nor by exercise.

Conclusions: The probiotic treatment decreased Zonulin in feces, a marker indicating enhanced gut permeability. Moreover, probiotic supplementation beneficially affected TNF-α and exercise induced protein oxidation. These results demonstrate promising benefits for probiotic use in trained men.

Clinical trial registry: http://www.clinicaltrials.gov, identifier: NCT01474629.

Figures

Figure 1
Figure 1
CONSORT diagram.
Figure 2
Figure 2
Stool concentrations of zonulin in trained men before and after 14 weeks of treatment. Pro with probiotics supplemented group, Plac placebo group, Tx treatment, wk week; n = 11 (probiotic supplementation), n = 12 (placebo). Values are means ± SD. There was a signficant difference between groups after 14 wk of treatment: PTx < 0.05 (ANOVA).
Figure 3
Figure 3
Plasma concentrations of carbonyl groups bounded on protein in trained men before and after 14 weeks of treatment, and pre/post a triple step test cycle ergometry. Pro with probiotics supplemented group, Plac placebo group, Ex exercise, Tx treatment, wk week; n = 11 (probiotic supplementation), n = 12 (placebo). Values are means ± SD. There was a significant differences from pre to post exercise (except “Pro wk14”): PEx < 0.05; and a tendential difference between groups after 14 wk of treatment: PTx < 0.1 (ANOVA).
Figure 4
Figure 4
Plasma concentrations of tumor necrosis factor-alpha in trained men before and after 14 weeks of treatment, and pre/post a triple step test cycle ergometry. Pro with probiotics supplemented group, Plac placebo group, Tx treatment, wk week; n = 11 (probiotic supplementation), n = 12 (placebo). Values are means ± SD. There was a tendential difference between groups after 14 wk of treatment: PTx < 0.1 (ANOVA).
Figure 5
Figure 5
Plasma concentrations of interleukin-6 in trained men before and after 14 weeks of treatment, and pre/post a triple step test cycle ergometry. Pro with probiotics supplemented group, Plac placebo group, Ex exercise, wk week; n = 11 (probiotic supplementation), n = 12 (placebo). Values are means ± SD. There were significant differences from pre to post exercise: PEx < 0.05 (ANOVA).

References

    1. Salminen S, Bouley D, Bourron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I. Functional food sciene and gastrointestinal physiology and function. Br J Nutr. 1998;80(Suppl):S147–S171.
    1. Gleeson M, Bishop NC, Oliveira M, Tauler P. Daily probiotic’s (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab. 2011;21:55–64.
    1. Cox AJ, Pyne DB, Saunders PU, Fricker PA. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med. 2010;44:222–226. doi: 10.1136/bjsm.2007.044628.
    1. Kekkonen RA, Vasankari TJ, Vuorimaa T, Haahtela T, Julkunen I, Korpela R. The effect of probiotics on respiratory infections and gastrointestinal symptoms during training in marathon runners. Int J Sport Nutr Exerc Metab. 2007;17:352–363.
    1. West NP, Pyne DB, Cripps AW, Hopkins WG, Eskesen DC, Jairath A, Christophersen CT, Conlon MA, Fricker PA. Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athlets. Nutr J. 2011;10:30. doi: 10.1186/1475-2891-10-30.
    1. Martarelli D, Verdenelli MC, Scuri S, Cocchioni M, Silvi S, Cecchini C, Pompei P. Effect of a probiotic intake on oxidant and antioxidant parameters in plasma of athletes during intense exercise training. Curr Microbiol. 2011;62:1689–1696. doi: 10.1007/s00284-011-9915-3.
    1. Rehrer NJ, Brouns F, Beckers EJ, Frey WO, Villiger B, Riddoch CJ, Menheere PP, Saris WH. Physiological changes and gastro-intestinal symptoms as a result of ultra-endurance running. Eur J Appl Physiol Occup Physiol. 1992;64:1–8. doi: 10.1007/BF00376431.
    1. Qarnar MI, Read AE. Effects of exercise on mesenteric blood flow in man. Gut. 1987;28:583–587. doi: 10.1136/gut.28.5.583.
    1. Lambert GP. Stress-induced gastrointestinal barrier dysfunction and ist inflammatory effects. J Anim Sci. 2009;87(E.Suppl):E101–E108.
    1. West NP, Pyne DB, Peake JM, Cripps AW. Probiotics, immunity and exercise: a review. Exerc Immunol Rev. 2009;15:107–126.
    1. Fasano A. Leaky gut and autoimmune diseases. Clinic Rev Allerg Immunol. 2012;42:71–78. doi: 10.1007/s12016-011-8291-x.
    1. DeOliveira EP, Burini RC. Food-dependent, exercise-induced gastrointestinal distress. J Int Soc Sports Nutr. 2011;8:12. doi: 10.1186/1550-2783-8-12.
    1. Fasano A. In: Tight Junctions. 2. Cereijido M, Anderson J, editor. CRC Press, Boca Raton; Pathological and therapeutical implications of macro-molecule passage through the tight junction. 2001:697-722.
    1. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 2011;141:769–776. doi: 10.3945/jn.110.135657.
    1. Qin H, Zhang Z, Hang X, Jiang YL. L. plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 2009;9:63. doi: 10.1186/1471-2180-9-63.
    1. Anderson RC, Cookson AL, McNabb WC, Kelly WJ, Roy NC. Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiol Lett. 2010;309:184–192.
    1. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJM, Wells JM. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 2010;298:G851–G859. doi: 10.1152/ajpgi.00327.2009.
    1. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology. 2006;130:731–746. doi: 10.1053/j.gastro.2005.12.015.
    1. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W, Bleich A, Bruder D, Franzke A, Rogler G. et al.Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One. 2007;12:e1308.
    1. Ghadimi D, Vrese MD, Heller KJ, Schrezenmeir J. Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integrity of polarized intestinal epithelial cells. Inflamm Bowel Dis. 2010;16:410–427.
    1. Fasano A. Zonulin and ist regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91:151–175. doi: 10.1152/physrev.00003.2008.
    1. Groschowitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009;124:3–20. doi: 10.1016/j.jaci.2009.05.038.
    1. Sonier B, Patrick C, Ajjikuttira P, Scott FW. Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity. Int Rev Immunol. 2009;28:414–445. doi: 10.3109/08830180903208329.
    1. Commission of experts of the German Society of Sports Medicine and Prevention. Guidelines for testing in sports medicine. Plane IV. Germany: Commission of experts of the German Society of Sports Medicine and Prevention; 2002. Expertenkommission der Deutschen Gesellschaft für Sportmedizin und Prävention: Leitlinien zur Belastungsuntersuchung in der Sportmedizin. Ebene IV. Deutsche Gesellschaft für Sportmedizin und Prävention, März 2002 (German)
    1. Möller R, Tafeit E, Smolle KH, Pieber TR, Ipsiroglu O, Duesse M, Huemer C, Sudi K, Reibnegger G. Estimating percentage total body fat and determining subcutaneous adipose tissue distribution with a new non-invasive optical device Lipometer. Am J Hum Biol. 2000;12:221–230. doi: 10.1002/(SICI)1520-6300(200003/04)12:2<221::AID-AJHB8>;2-2.
    1. Young DS. Implementation of SI units for clincal laboratory tables - style specifications and conversion tables. Ann Intern Med. 1987;106:114–129.
    1. German Nutrition Society, Austrian Nutrition Society, Swiss Association of Nutrition: Reference values for nutrient intake, 3rd revision of the 1st issue.Umschau Braus Ltd:Frankfurt; 2008.Deutsche Gesellschaft für Ernährung (DGE), Österreichische Gesellschaft für Ernährung (ÖGE), Schweizerische Vereinigung für Ernährung (SVE): Referenzwerte für die Nährstoffzufuhr. 3. korrigierter Nachdruck der 1. Auflage. Frankfurt: Umschau Braus GmbH; 2008 (German)
    1. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920–924. doi: 10.3109/00365529709011203.
    1. Pilz J, Meinekea I, Gleitera CH. Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenyl-hydrazine derivative. J Chromatogr B Biomed Sci Appl. 2000;742:315–325. doi: 10.1016/S0378-4347(00)00174-2.
    1. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol. 1999;73:1265–1272.
    1. Baska RS, Moses FM, Graeber G, Kearney G. Gastrointestinal bleeding during an ultramarathon. Dig Dis Sci. 1990;35:276–279. doi: 10.1007/BF01536777.
    1. Eichner ER. Gastrointestinal bleeding in athletes. Physician Sportsmed. 1989;17:128–140.
    1. Oktedalen O, Lunde OC, Opstad PK, Aabakken L, Kvernebo K. Changes in the gastrointestinal mucosa after long-distance running. Scand J Gastroenterol. 1992;27:270–274. doi: 10.3109/00365529209000073.
    1. Pals KL, Chang R-T, Ryan AJ, Gisolfi CV. Effect of running intensity on intestinal permeability. J Appl Physiol. 1997;82:571–576.
    1. Fasano A. Intestinal zonulin: open sesame! Gut. 2001;49:159–162. doi: 10.1136/gut.49.2.159.
    1. Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, Lampis R, Kryszak D, Carteni M, Generoso M, Iafusco D, Prisco F, Laghi F, Riegler G, Carratu R, Counts D, Fasano A. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55:1443–1449. doi: 10.2337/db05-1593.
    1. Wang W, Uzzau S, Goldblum SE, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci. 2000;113:4435–4440.
    1. El Asmar R, Panigrahi P, Bamford P, Berti I, Not R, Coppa GV, Catassi C, Fasano A. Host-dependent activation of the zonulin system is involved in the impairment of the gut barrier function following bacterial colonization. Gastroenterology. 2002;123:1607–1615. doi: 10.1053/gast.2002.36578.
    1. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. PNAS. 2011;108(Suppl 1):4607–4614.
    1. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenerology. 2004;127:224–238. doi: 10.1053/j.gastro.2004.04.015.
    1. Koning CJM, Jonkers DMAE, Stobberingh EE, Mulder L, Rombouts FM, Stockbruegger RW. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic Amoxycillin. Am J Gastroenterol. 2007;102:1–12. doi: 10.1111/j.1572-0241.2007.01057.x.
    1. Jeukendrup AE, Vet-Joop K, Sturk A, Stegen JHJC, Senden J, Saris WHM, Wagenmakers AJM. Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin Sci. 2000;98:47–55. doi: 10.1042/CS19990258.
    1. Fujii T, Shimizu T, Takahashi K, Kishiro M, Ohkubo M, Akimoto K, Yamashiro Y. Fecal α1-antitrpysin concentrations as a measure of enteric protein loss after modified fontan operations. J Pediatr Gastroenterol Nutr. 2003;37:577–580. doi: 10.1097/00005176-200311000-00014.
    1. Strygler B, Nicar MJ, Santangelo WC, Porter JL, Fordtran JS. Alpha1-antritrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterology. 1990;99:1380–1387.
    1. Levine RL, Stadtman ER. Oxidative modification of proteins during aging. Exp Gerontol. 2001;36:1495–1502. doi: 10.1016/S0531-5565(01)00135-8.
    1. Pantke U, Volk T, Schmutzler M, Kox WJ, Sitte N, Grune T. Oxidized proteins as a marker during coronary heart surgery. Free Radic Biol Med. 1999;27:1080–1086. doi: 10.1016/S0891-5849(99)00144-6.
    1. Lamprecht M, Oettl K, Schwaberger G, Hofmann P, Greilberger JF. Several indicators of oxidative stress, immunity, and illness improved in trained men consuming an encapsulated juice powder concentrate for 28 weeks. J Nutr. 2007;137:2737–2741.
    1. Lamprecht M, Oettl K, Schwaberger G, Hofmann P, Greilberger JF. Protein modification responds to exercise intensity and antioxidant supplementation. Med Sci Sport Exerc. 2009;41:155–163.
    1. Deepa D, Jayakumari B, Thomas SV. Lipid peroxidation in women with epilepsy. Ann Indian Acad Neurol. 2008;11:44–46. doi: 10.4103/0972-2327.40225.
    1. Lamprecht M, Hofmann P, Greilberger JF, Schwaberger G. Increased lipid peroxidation in trained men after 2 weeks of antioxidant supplementation. Int J Sport Nutr Exerc Metab. 2009;19:385–399.
    1. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med. 1991;11:81–128. doi: 10.1016/0891-5849(91)90192-6.
    1. Febbraio MA, Pedersen BK. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 2002;16:1335–1347. doi: 10.1096/fj.01-0876rev.
    1. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005;98:1154–1162. doi: 10.1152/japplphysiol.00164.2004.

Source: PubMed

3
Předplatit